Similar articles for PMID: 27913706

Year	Number of Results
2007	4
2008	5
2009	1
2011	2
2012	2
2013	5
2014	3
2015	13
2016	13
2017	9
2018	7
2019	7
2020	2
2021	2
2022	2
2023	1
2024	0

1

STAT1 Promotes KRAS Colon Tumor Growth and Susceptibility to Pharmacological Inhibition of Translation Initiation Factor eIF4A.

Wang S, Darini C, Désaubry L, Koromilas AE. Wang S, et al. Mol Cancer Ther. 2016 Dec;15(12):3055-3063. doi: 10.1158/1535-7163.MCT-16-0416. Mol Cancer Ther. 2016. PMID: 27913706

2

Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs.

Wang S, Patsis C, Koromilas AE. Wang S, et al. Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2149-55. doi: 10.1073/pnas.1420671112. Epub 2015 Apr 13. Proc Natl Acad Sci U S A. 2015. PMID: 25870277 Free PMC article.

3

Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.

Singh K, Lin J, Lecomte N, Mohan P, Gokce A, Sanghvi VR, Jiang M, Grbovic-Huezo O, Burčul A, Stark SG, Romesser PB, Chang Q, Melchor JP, Beyer RK, Duggan M, Fukase Y, Yang G, Ouerfelli O, Viale A, de Stanchina E, Stamford AW, Meinke PT, Rätsch G, Leach SD, Ouyang Z, Wendel HG. Singh K, et al. Cancer Res. 2021 Apr 15;81(8):2002-2014. doi: 10.1158/0008-5472.CAN-20-2929. Epub 2021 Feb 25. Cancer Res. 2021. PMID: 33632898 Free PMC article.

4

A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells.

Inoue A, Mizushima T, Wu X, Okuzaki D, Kambara N, Ishikawa S, Wang J, Qian Y, Hirose H, Yokoyama Y, Ikeshima R, Hiraki M, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M, Yamamoto H. Inoue A, et al. Mol Cancer Ther. 2018 May;17(5):977-987. doi: 10.1158/1535-7163.MCT-17-0850. Epub 2018 Mar 15. Mol Cancer Ther. 2018. PMID: 29545333

5

Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.

Klingbeil O, Lesche R, Gelato KA, Haendler B, Lejeune P. Klingbeil O, et al. Cell Death Dis. 2016 Sep 8;7(9):e2365. doi: 10.1038/cddis.2016.271. Cell Death Dis. 2016. PMID: 27607580 Free PMC article.

6

Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.

Liwak U, Thakor N, Jordan LE, Roy R, Lewis SM, Pardo OE, Seckl M, Holcik M. Liwak U, et al. Mol Cell Biol. 2012 May;32(10):1818-29. doi: 10.1128/MCB.06317-11. Epub 2012 Mar 19. Mol Cell Biol. 2012. PMID: 22431522 Free PMC article.

7

Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.

Okamoto K, Zaanan A, Kawakami H, Huang S, Sinicrope FA. Okamoto K, et al. Mol Cancer Res. 2015 Apr;13(4):659-69. doi: 10.1158/1541-7786.MCR-14-0476. Epub 2014 Dec 29. Mol Cancer Res. 2015. PMID: 25548100 Free PMC article.

8

Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.

Wang Q, Zhu J, Wang YW, Dai Y, Wang YL, Wang C, Liu J, Baker A, Colburn NH, Yang HS. Wang Q, et al. Oncogene. 2017 Nov 9;36(45):6225-6234. doi: 10.1038/onc.2017.228. Epub 2017 Jul 10. Oncogene. 2017. PMID: 28692058 Free PMC article.

9

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.

Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ. Jung SA, et al. Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22. Free Radic Biol Med. 2016. PMID: 27012422

10

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models.

Oliveras-Ferraros C, Vazquez-Martin A, Queralt B, Adrados M, Ortiz R, Cufí S, Hernández-Yagüe X, Guardeño R, Báez L, Martin-Castillo B, Pérez-Martínez MC, Lopez-Bonet E, De Llorens R, Bernadó L, Brunet J, Menendez JA. Oliveras-Ferraros C, et al. Int J Oncol. 2011 Dec;39(6):1455-79. doi: 10.3892/ijo.2011.1155. Epub 2011 Aug 9. Int J Oncol. 2011. PMID: 21833472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year